Autolus Therapeutics Plc (AUTL)

Trade AUTL now with
4/19/2021 7:08:14 AM Autolus Therapeutics Names Martin Murphy Non-executive Chairman Of Its Board
5/29/2020 7:42:02 AM Autolus Therapeutics Presents New Data On Phase 1/2 Study Of AUTO3 In R/r DLBCL During ASCO20 Virtual Scientific Program
4/16/2020 7:12:58 AM Autolus Therapeutics Announces FDA Acceptance Of IND Application For AUTO1 For Adult Acute Lymphoblastic Leukemia
12/9/2019 2:08:25 AM Autolus Therapeutics Reports New Data Highlighting Progress On Next-generation Programmed T Cell Therapies At ASH
9/16/2019 9:16:23 AM PPF Announces Acquisition Of 19.2% Stake In Autolus Therapeutics Plc
4/10/2019 10:42:34 PM Autolus Therapeutics Announces Pricing Of Underwritten Public Offering Of 4.20 Mln ADSs At $24.00/ADS
2/25/2019 6:30:11 AM Vineti Announces Strategic Partnership With Autolus Therapeutics
2/25/2019 6:04:49 AM Autolus Therapeutics 3-month Loss Per Share $0.52 Vs Loss $0.26 Last Year
2/19/2019 6:37:31 AM Autolus Therapeutics Says Updated Results From CARPALL Trial Presented At The EHA 1st European CAR T Cell Meeting
1/14/2019 7:56:27 AM Autolus Therapeutics Enters Lease With Alexandria Real Estate Equities
12/3/2018 3:30:30 AM Arix Bioscience: Autolus Announces Update On AUTO4 And AUTO5 Programmes
12/3/2018 3:28:27 AM Arix Bioscience Portfolio Company Autolus Presents Initial AUTO3 Clinical Data At ASH
12/1/2018 10:53:14 PM Autolus Therapeutics Updates On Its Novel CAR T Cell Program For Peripheral T Cell Lymphoma
11/27/2018 7:14:48 AM William Blair Is Cutting Autolus Therapeutics plc (AUTL) FY20 Estimate To -2.21 From -2.11